The CRC group aims to advance biomedical research by developing new methods for radiolabelling, designing radiotracers for nuclear imaging, and translating diagnostic agents to human studies. We focus on the design of new chemical reactions, radiotracers and imaging approaches that are readily translatable, and have the potential to change clinical practise and ultimately, to improve patient benefit. To this end, we collaborate closely with clinical as well as industrial partners both across UCL and internationally.
Close
